Endo Raises 2018 Financial Guidance - Quick Facts

(RTTNews) - Endo International plc (ENDP) announced, for fiscal year 2018, the company now estimates: total revenues to be between $2.87 billion and $2.92 billion; and adjusted diluted EPS from continuing operations to be between $2.65 and $2.75.

For the third-quarter, adjusted diluted EPS from continuing operations was $0.71 compared to $0.91, prior year. Revenues were $745 million, a decrease of 5 percent compared to third-quarter 2017. XIAFLEX franchise revenues increased 22 percent, while Sterile Injectables revenues increased 17 percent versus third-quarter 2017.